Treatment of PERitoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: the PERISCOPE II study.
Latest Information Update: 14 Mar 2024
Price :
$35 *
At a glance
- Drugs Docetaxel (Primary) ; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms PERISCOPE II-study; PERISCOPEII
- 14 Feb 2022 Planned End Date changed from 14 Jul 2021 to 1 Oct 2029.
- 14 Feb 2022 Planned primary completion date changed from 1 Oct 2021 to 1 Oct 2026.
- 06 May 2021 Planned number of patients changed from 106 to 182.